<code id='D090A6BDA1'></code><style id='D090A6BDA1'></style>
    • <acronym id='D090A6BDA1'></acronym>
      <center id='D090A6BDA1'><center id='D090A6BDA1'><tfoot id='D090A6BDA1'></tfoot></center><abbr id='D090A6BDA1'><dir id='D090A6BDA1'><tfoot id='D090A6BDA1'></tfoot><noframes id='D090A6BDA1'>

    • <optgroup id='D090A6BDA1'><strike id='D090A6BDA1'><sup id='D090A6BDA1'></sup></strike><code id='D090A6BDA1'></code></optgroup>
        1. <b id='D090A6BDA1'><label id='D090A6BDA1'><select id='D090A6BDA1'><dt id='D090A6BDA1'><span id='D090A6BDA1'></span></dt></select></label></b><u id='D090A6BDA1'></u>
          <i id='D090A6BDA1'><strike id='D090A6BDA1'><tt id='D090A6BDA1'><pre id='D090A6BDA1'></pre></tt></strike></i>

          leisure time

          leisure time

          author:entertainment    Page View:342
          James Fanale, the former CEO and president of Care New England, and his wife Deb (left) on their front porch. -- health coverage from STAT
          Courtesy Ryan Pickering

          PROVIDENCE – In late August, Dr. James E. Fanale was trudging through the Falmouth Road Race — walking up the hills, running down them — for seven miles. Fellow runners encouraged him to “keep trying” whenever he slowed down. But they couldn’t have known — along with most of the people in Fanale’s professional orbit — that he was battling Stage 4 lung cancer.

          “Many times, I wanted to say ‘Listen buddy, you don’t know what I’ve got in me,’” Fanale recalled recently with a chuckle.

          advertisement

          In December 2022, on the day Fanale retired as president and CEO of Care New England, he shared his diagnosis with a Globe reporter but requested it be kept private. He was handing the reins to new CEO Dr. Michael Wagner after six years leading the second largest health care system in Rhode Island.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          An interview with Robert F. Kennedy Jr. on vaccines
          An interview with Robert F. Kennedy Jr. on vaccines

          RobertF.KennedyJr.talkswithreportersinthelobbyofTrumpTowerinJanuary2017.EvanVucci/APIntheearlydaysof

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo